With the House successfully passing President Joe Biden’s $1.9 trillion COVID-19 relief bill, it is now in the hands of the Senate. Biden makes another strong push for the passage of the bill in his latest meeting with Senate Democrats.
Biden sat down with Senate Democrats in a virtual meeting Tuesday to talk about the sweeping COVID-19 relief package he has proposed. People knowledgeable of the meeting revealed to CNN that Biden told the Democratic lawmakers that in order to successfully pass the relief plan, they would need to accept some provisions that may not necessarily be favorable to them. Biden reportedly noted that they must show the American public that they are determined to respond to the ongoing pandemic and the economic collapse it has caused.
The President met with Senate Democrats for lunch for 15 minutes and did not take questions. Biden did not get into specifics with regards to the ongoing debates that are occurring within the Democrats in the upper chamber. The ongoing debates among Democrats have involved whether or not to reduce unemployment benefits to $300 a week from $400 a week as passed by the House. West Virginia Democrat Joe Manchin has said he supports the $300 a week level, but it has put him at odds with Delaware Senator Chris Coons, who opposed reducing the benefit.
Montana Democrat Jon Tester said that modest changes may ultimately be made to the COVID-19 relief plan in order for it to pass. Nevertheless, they all appear to agree not to reduce the overall cost of $1.9 trillion.
Meanwhile, Biden made an announcement regarding the COVID-19 vaccines. Biden announced that the US expects to be able to ship out enough COVID-19 vaccines for all adults until the end of May which is two months earlier than he had previously estimated. Biden also pushed for states to vaccinate teachers at least once by the end of March in order to speed up the reopenings of schools.
Pharmaceutical company Merck has also been announced to produce its rival Johnson & Johnson’s one-shot vaccine that has been recently approved by the FDA.


FEMA Reinstates $1 Billion Disaster Prevention Grant Program After Court Order
Trump Signs Executive Order to Pay TSA Workers Amid Airport Security Crisis
U.S. Praises Kurdistan's Role in Oil Markets Amid Iran War Fallout
Maduro Faces Rare Narcoterrorism Charges in U.S. Court
WTO Reform Talks Begin in Cameroon Amid Global Trade Tensions
G7 Summit 2026: South Africa Excluded Amid U.S. Pressure, Kenya Invited Instead
Iran Demands Lebanon Be Part of Any Ceasefire Deal With Israel and the U.S.
Trump Pauses Iran Strikes as Peace Talks Stall Amid Military Buildup
CPAC 2026: Republicans Back Trump's Iran Strikes Amid Growing Public Skepticism
What does China’s host bid mean for the High Seas Treaty?
SMIC Allegedly Supplies Chipmaking Tools to Iran's Military, U.S. Officials Warn
G7 Foreign Ministers Gather in France Amid Global Tensions and U.S. Policy Uncertainty
Chinese Universities with PLA Ties Found Purchasing Restricted U.S. AI Chips Through Super Micro Servers
US Military Eyes 10,000 Troop Surge to Middle East Amid Iran Nuclear Tensions
Russia Strikes Kharkiv and Izmail as Cross-Border Drone War Escalates
Jay Bhattacharya to Continue Leading CDC as White House Searches for Permanent Director 



